Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127465421 | 12746542 | 1 | I | 20140728 | 20160623 | 20160915 | 20160915 | EXP | JP-JNJFOC-20160623521 | JANSSEN | TOKUMOTO Y, WATANABE T, YOSHIDA O, HIROOKA M, ABE M, HIASA Y, ET AL. TREATMENT OUTCOME OF ANTIVIRAL THERAPY FOR RECURRENT CHRONIC HEPATITIS C AFTER LIVER TRANSPLANTATION: A SINGLE CENTER EXPERIENCE. APR-2016:144. | 55.00 | YR | A | M | Y | 0.00000 | 20160915 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127465421 | 12746542 | 1 | PS | SOVRIAD | SIMEPREVIR | 1 | Oral | N | 205123 | 100 | MG | CAPSULE | QD | ||||||
| 127465421 | 12746542 | 2 | SS | COPEGUS | RIBAVIRIN | 1 | Oral | 0 | 600 | MG | TABLET | QD | |||||||
| 127465421 | 12746542 | 3 | SS | PEGASYS | PEGINTERFERON ALFA-2A | 1 | Intramuscular | Y | 0 | 180 | UG | INJECTION | /wk | ||||||
| 127465421 | 12746542 | 4 | SS | PEGASYS | PEGINTERFERON ALFA-2A | 1 | Intramuscular | Y | 0 | 90 | UG | INJECTION | /wk | ||||||
| 127465421 | 12746542 | 5 | SS | PEGASYS | PEGINTERFERON ALFA-2A | 1 | Intramuscular | Y | 0 | 180 | UG | INJECTION | /wk | ||||||
| 127465421 | 12746542 | 6 | SS | PEGASYS | PEGINTERFERON ALFA-2A | 1 | Intramuscular | Y | 0 | 90 | UG | INJECTION | /wk | ||||||
| 127465421 | 12746542 | 7 | SS | PEGASYS | PEGINTERFERON ALFA-2A | 1 | Intramuscular | Y | 0 | 180 | UG | INJECTION | /wk | ||||||
| 127465421 | 12746542 | 8 | SS | PEGASYS | PEGINTERFERON ALFA-2A | 1 | Intramuscular | Y | 0 | 90 | UG | INJECTION | /wk | ||||||
| 127465421 | 12746542 | 9 | SS | PEGASYS | PEGINTERFERON ALFA-2A | 1 | Intramuscular | Y | 0 | 180 | UG | INJECTION | /wk | ||||||
| 127465421 | 12746542 | 10 | SS | PEGASYS | PEGINTERFERON ALFA-2A | 1 | Intramuscular | Y | 0 | 90 | UG | INJECTION | /wk | ||||||
| 127465421 | 12746542 | 11 | SS | PEGASYS | PEGINTERFERON ALFA-2A | 1 | Intramuscular | Y | 0 | 180 | UG | INJECTION | /wk | ||||||
| 127465421 | 12746542 | 12 | C | BAYASPIRIN | ASPIRIN | 1 | Oral | 0 | TABLET | ||||||||||
| 127465421 | 12746542 | 13 | C | WARFARIN | WARFARIN | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 127465421 | 12746542 | 14 | C | MUCOSTA | REBAMIPIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 127465421 | 12746542 | 15 | C | PROGRAF | TACROLIMUSTACROLIMUS ANHYDROUS | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 127465421 | 12746542 | 16 | C | MAGLAX | MAGNESIUM OXIDE | 1 | Oral | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127465421 | 12746542 | 1 | Antiviral prophylaxis |
| 127465421 | 12746542 | 2 | Antiviral treatment |
| 127465421 | 12746542 | 3 | Antiviral treatment |
| 127465421 | 12746542 | 4 | Antiviral treatment |
| 127465421 | 12746542 | 5 | Antiviral treatment |
| 127465421 | 12746542 | 6 | Antiviral treatment |
| 127465421 | 12746542 | 7 | Antiviral treatment |
| 127465421 | 12746542 | 8 | Antiviral treatment |
| 127465421 | 12746542 | 9 | Antiviral treatment |
| 127465421 | 12746542 | 10 | Antiviral treatment |
| 127465421 | 12746542 | 11 | Antiviral treatment |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127465421 | 12746542 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127465421 | 12746542 | Neutrophil count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127465421 | 12746542 | 1 | 20140714 | 20141005 | 0 | |
| 127465421 | 12746542 | 2 | 20140714 | 20141222 | 0 | |
| 127465421 | 12746542 | 3 | 20140804 | 20140811 | 0 | |
| 127465421 | 12746542 | 4 | 20140728 | 20140728 | 0 | |
| 127465421 | 12746542 | 5 | 20140714 | 20140722 | 0 | |
| 127465421 | 12746542 | 6 | 20140818 | 20140818 | 0 | |
| 127465421 | 12746542 | 7 | 20141208 | 20141222 | 0 | |
| 127465421 | 12746542 | 8 | 20141104 | 20141201 | 0 | |
| 127465421 | 12746542 | 9 | 20140825 | 20140929 | 0 | |
| 127465421 | 12746542 | 10 | 20141006 | 20141014 | 0 | |
| 127465421 | 12746542 | 11 | 20141020 | 20141027 | 0 |